Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

INVENTORY

v3.25.1
INVENTORY
12 Months Ended
Dec. 31, 2024
Classes of current inventories [abstract]  
INVENTORY [Text Block]
NOTE 7 -
INVENTORY

 

   
December 31, 2024
 
   
Capitalized costs
   
Fair valuation adjustment, net
   
Carrying value
 
Work in progress:
                 
Bulk cannabis
 
$
325
   
$
-
   
$
325
 
Finished goods:
                       
Packaged dried cannabis
   
2,605
     
-
     
2,605
 
Other products
   
285
     
-
     
285
 
                         
Balance as of December 31, 2024
 
$
3,215
   
$
-
   
$
3,215
 
 
   
December 31, 2023
 
   
Capitalized costs
   
Fair valuation adjustment, net
   
Carrying value
 
Work in progress:
                 
Bulk cannabis
 
$
3,735
   
$
-
   
$
3,735
 
Finished goods:
                       
Packaged dried cannabis
   
4,667
     
984
     
5,651
 
Other products
   
590
     
-
     
590
 
                         
Balance as of December 31, 2023
 
$
8,992
   
$
984
   
$
9,976
 
 
During the years ended December 31, 2024, 2023 and 2022, inventory expensed to cost of revenue of cannabis products, including inventory write-off, was $43,199, $35,154 and $63,517, respectively, which included $nil, $984 and $4,342 of non-cash expense (a total of $2,528 out of which attributable to discontinued operations of the Canadian entities in 2022, see Note 21 below), respectively, related to the changes in fair value of inventory sold or impaired. In addition, during the years ended December 31, 2024, 2023 and 2022, cost of revenue also include production overhead not allocated to costs of inventory produced and recognized as an expense, as incurred.